| 000 | 01514 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517145949.0 | ||
| 264 | 0 | _c20180515 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1093/cid/cix313 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdimora, Adaora A | |
| 245 | 0 | 0 |
_aUS Black Women and Human Immunodeficiency Virus Prevention: Time for New Approaches to Clinical Trials. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJul 2017 |
||
| 300 |
_a324-327 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlack or African American |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 |
_aEmtricitabine _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMedication Adherence |
| 650 | 0 | 4 | _aPre-Exposure Prophylaxis |
| 650 | 0 | 4 | _aRacism |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aSample Size |
| 650 | 0 | 4 |
_aTenofovir _xblood |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aCole, Stephen R | |
| 700 | 1 | _aEron, Joseph J | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 65 _gno. 2 _gp. 324-327 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/cix313 _zAvailable from publisher's website |
| 999 |
_c27055765 _d27055765 |
||